Cannabidiol promotes browning in 3T3-L1 adipocytes

  title={Cannabidiol promotes browning in 3T3-L1 adipocytes},
  author={Hilal Ahmad Parray and Jong Won Yun},
  journal={Molecular and Cellular Biochemistry},
Recruitment of the brown-like phenotype in white adipocytes (browning) and activation of existing brown adipocytes are currently being investigated as a means to combat obesity. [] Key Result CBD enhanced expression of a core set of brown fat-specific marker genes (Ucp1, Cited1, Tmem26, Prdm16, Cidea, Tbx1, Fgf21, and Pgc-1α) and proteins (UCP1, PRDM16, and PGC-1α).
Trans-Cinnamic Acid Stimulates White Fat Browning and Activates Brown Adipocytes
Trans-cinnamic acid (tCA), a class of cinnamon from the bark of Cinnamomum cassia, is evaluated for its potential to treat obesity and mechanistic study revealed that tCA induced browning in white adipocytes by activating the β3-AR and AMPK signaling pathways.
L‐rhamnose induces browning in 3T3‐L1 white adipocytes and activates HIB1B brown adipocytes
This is the first study to demonstrate that L‐rhamnose plays multiple modulatory roles in the induction of white fat browning, activation of brown adipocytes, as well as promotion of lipid metabolism, thereby demonstrating its therapeutic potential for treatment of obesity.
The Mechanism of Leptin on Inhibiting Fibrosis and Promoting Browning of White Fat by Reducing ITGA5 in Mice
Overall, the research shows that leptin can inhibit the activation of phosphatidylinositol 3 kinase (PI3K)-protein kinase B (AKT) signaling pathway by reducing the expression of ITGA5, which could alleviate adipose tissue fibrosis, and further promote white fat browning.
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
The pharmacological properties of CBD are highlighted as well as its impact on obesity in different tissues in a review of potential therapeutic properties of Cannabis derivatives.
Recent developments in natural products for white adipose tissue browning.


Ginsenoside Rb1 promotes browning through regulation of PPARγ in 3T3-L1 adipocytes.
Acquirement of Brown Fat Cell Features by Human White Adipocytes*
It is shown that PGC-1α is able to direct human WAT PPARγ toward a transcriptional program linked to energy dissipation, and that Alteration of energy balance through an increased utilization of fat in WAT may be a conceivable strategy for the treatment of obesity.
Increased mitochondrial activity in BMP7-treated brown adipocytes, due to increased CPT1- and CD36-mediated fatty acid uptake.
These findings uncover a novel pathway regulating mitochondrial activities in mature brown adipocytes by BMP7-mediated fatty acid uptake and oxidation, which requires the fatty acid transporters CPT1 and CD36.
Brown and beige fat: development, function and therapeutic potential
Many genes and pathways that regulate brown and beige adipocyte biology have now been identified, providing a variety of promising therapeutic targets for metabolic disease.
A novel JNK2/SREBP-1c pathway involved in insulin-induced fatty acid synthesis in human adipocytes
The results suggest that SREBP-1c is a novel insulin/JNK2-regulated gene and that the JNK2/SREBP1c pathway mediates insulin-induced fatty acid synthesis, which may lead to enlargement of LDs in human adipocytes.
Adipose tissue browning and metabolic health
Stimulating the development of beige adipocytes in WAT (so called 'browning') might reduce adverse effects of WAT and could help to improve metabolic health, as well as inspire new avenues to increase the capacity for adaptive thermogenesis.
Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice.
It is demonstrated that Prdm16 is a cell-autonomous determinant of a brown fat-like gene program and thermogenesis in subcutaneous adipose tissues and reduced the brown fat phenotype in white adipose tissue stimulated by β-adrenergic agonists.
Positive and negative control of Ucp1 gene transcription and the role of β-adrenergic signaling networks
Evidence is provided for an important role for the nuclear receptor LXRα as a cAMP- and oxysterol-dependent transcriptional repressor of the UCP1 gene, which reveals potential new targets and directions for controlling the relative levels of white versus brown adipocytes as a means of metabolic fuel utilization in the struggle against obesity and related metabolic diseases.